Agilent Technologies, Inc. (A) – Financial and Strategic SWOT Analysis Review

Agilent Technologies, Inc. (A) – Financial and Strategic SWOT Analysis Review Cover

Single Licence: $125

Buy Now
customer(s) bought this report
BUY WITH CONFIDENCE

Shopping on CFDMaster.com is Safe and Secure. GUARANTEED!
All information is encrypted and handled by PayPal.com

Need Assistance?
Have you got questions about this report? Why not speak to one of our advisors. Email us at business@cfdmaster.com or call us at +61 (02) 8011 3208
# Pages
Market
Country
Single User
Site License
Enterprisewide
63
Medical Devices
United States

Agilent Technologies, Inc. (A) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

– Business description – A detailed description of the company’s operations and business divisions.
– Corporate strategy – Analyst’s summarization of the company’s business strategy.
– SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
– Company history – Progression of key events associated with the company.
– Major products and services – A list of major products, services and brands of the company.
– Key competitors – A list of key competitors to the company.
– Key employees – A list of the key executives of the company.
– Executive biographies – A brief summary of the executives’ employment history.
– Key operational heads – A list of personnel heading key departments/functions.
– Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
– Key manufacturing facilities – A list of key manufacturing facilities of the company.
– Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
– Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Agilent Technologies, Inc. (Agilent) provides instruments, reagents, software, services and consumables for life sciences, diagnostics and applied chemical markets. The company offers its products to pharmaceutical, biotechnology, CRO and CMO, chemical and energy, environmental and forensics, and food industries. The company conducts research and development activities through its research arm Agilent Technologies Research Laboratories. The company markets its products through direct sales. It works with customers in more than 100 countries and it has subsidiaries in Denmark, Luxembourg, Netherlands, Singapore and Switzerland. Agilent is headquartered in Santa Clara, California, the US.
Agilent seeks to expand its position in the market through new product launches. Recently the company launched aloPlex target enrichment system, ClearSeq Comprehensive Cancer research panel, SureVector modular vector kit and Portable FTIR Package, among others.

Agilent Technologies, Inc. Key Recent Developments

Mar 18, 2015: Agilent Technologies Announces New CEO Mike McMullen
Mar 18, 2015: Daniel K. Podolsky, M.D., of University of Texas Southwestern Medical Center, to Join Agilent Technologies Board of Directors
Mar 09, 2015: Agilent Technologies Announces Major University Client for Informatics Software
Feb 25, 2015: Agilent Technologies Introduces OneSeq to Streamline Cytogenetic Research
Feb 18, 2015: Agilent Technologies Launches Innovative Cloning Kit

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
– The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
– Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
– Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
– Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Table of Contents

Section 1 – About the Company 6
Agilent Technologies, Inc. – Key Facts 6
Agilent Technologies, Inc. – Key Employees 7
Agilent Technologies, Inc. – Key Employee Biographies 9
Agilent Technologies, Inc. – Major Products and Services 11
Agilent Technologies, Inc. – Medical Equipment Pipeline Products Data 13
Agilent Technologies, Inc. Pipeline Products by Equipment Type 13
Agilent Technologies, Inc. Pipeline Products by Development Stage 14
Agilent Technologies, Inc. – History 15
Agilent Technologies, Inc. – Company Statement 24
Agilent Technologies, Inc. – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Section 2 – Company Analysis 30
Agilent Technologies, Inc. – Business Description 30
Agilent Technologies, Inc. – Corporate Strategy 31
Agilent Technologies, Inc. – SWOT Analysis 32
SWOT Analysis – Overview 32
Agilent Technologies, Inc. – Strengths 32
Strength – Life Sciences and Diagnostics Division 32
Strength – Success in International Markets 32
Strength – Research and Development 32
Agilent Technologies, Inc. – Weaknesses 33
Weakness – Safety Issues/Product Defects 33
Weakness – Declining Profitability 33
Weakness – Patent Infringement Concerns 33
Agilent Technologies, Inc. – Opportunities 34
Opportunity – Inorganic Growth Drivers: Acquisitions 34
Opportunity – Strategic Agreements & Collaborations 34
Opportunity – Product Innovation 34
Opportunity – Strategic Restructuring Initiatives 34
Agilent Technologies, Inc. – Threats 36
Threat – Competitive Atmosphere 36
Threat – Integration of Acquisitions 36
Threat – Stringent Government Regulations 36
Agilent Technologies, Inc. – Key Competitors 37
Section 3 – Company Financial Ratios 38
Financial Ratios – Capital Market Ratios 38
Financial Ratios – Annual Ratios 39
Performance Chart 41
Financial Performance 41
Financial Ratios – Interim Ratios 42
Financial Ratios – Ratio Charts 43
Section 4 – Company’s Lifesciences Financial Deals and Alliances 44
Agilent Technologies, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 44
Agilent Technologies, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015 45
Agilent Technologies, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 46
Agilent Technologies, Inc., Medical Equipment, Deals By Type, 2009 to YTD 2015 47
Agilent Technologies, Inc., Recent Deals Summary 48
Section 5 – Company’s Recent Developments 49
Mar 18, 2015: Agilent Technologies Announces New CEO Mike McMullen 49
Mar 18, 2015: Daniel K. Podolsky, M.D., of University of Texas Southwestern Medical Center, to Join Agilent Technologies Board of Directors 50
Mar 09, 2015: Agilent Technologies Announces Major University Client for Informatics Software 51
Feb 26, 2015: Agilent Technologies Introduces ClearSeq to Advance Clinical Cancer Research 52
Feb 25, 2015: Agilent Technologies Introduces OneSeq to Streamline Cytogenetic Research 53
Feb 18, 2015: Agilent Technologies Launches Innovative Cloning Kit 54
Feb 17, 2015: Agilent Technologies Reports First-Quarter 2015 Results 55
Jan 27, 2015: Agilent Gets Chinese Approval For SureScan Dx Microarray Scanner 56
Jan 16, 2015: Agilent Technologies Names Alacris Theranostics as Certified Provider of Target Enrichment Services 57
Jan 12, 2015: TRADE NEWS: Agilent Technologies Introduces Microarray for Rapid Screening of Aneuploidy in Single Cells from Embryos 58
Section 6 – Appendix 59
Methodology 59
Ratio Definitions 59
About GlobalData 63
Contact Us 63
Disclaimer 63



List of Tables
Agilent Technologies, Inc., Key Facts 6
Agilent Technologies, Inc., Key Employees 7
Agilent Technologies, Inc., Key Employee Biographies 9
Agilent Technologies, Inc., Major Products and Services 11
Agilent Technologies, Inc. Number of Pipeline Products by Equipment Type 13
Agilent Technologies, Inc. Pipeline Products by Equipment Type 13
Agilent Technologies, Inc. Number of Pipeline Products by Development Stage 14
Agilent Technologies, Inc. Pipeline Products by Development Stage 14
Agilent Technologies, Inc., History 15
Agilent Technologies, Inc., Subsidiaries 26
Agilent Technologies, Inc., Key Competitors 37
Agilent Technologies, Inc., Ratios based on current share price 38
Agilent Technologies, Inc., Annual Ratios 39
Agilent Technologies, Inc., Interim Ratios 42
Agilent Technologies, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 44
Agilent Technologies, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015 45
Agilent Technologies, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 46
Agilent Technologies, Inc., Medical Equipment, Deals By Type, 2009 to YTD 2015 47
Agilent Technologies, Inc., Recent Deals Summary 48
Currency Codes 59
Capital Market Ratios 59
Equity Ratios 60
Profitability Ratios 60
Cost Ratios 61
Liquidity Ratios 61
Leverage Ratios 62
Efficiency Ratios 62



List of Figures
Agilent Technologies, Inc. Pipeline Products by Equipment Type 13
Agilent Technologies, Inc. Pipeline Products by Development Stage 14
Agilent Technologies, Inc., Performance Chart (2010 – 2014) 41
Agilent Technologies, Inc., Ratio Charts 43
Agilent Technologies, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 44
Agilent Technologies, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 45
Agilent Technologies, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 46
Agilent Technologies, Inc., Medical Equipment, Deals by Type, 2009 to YTD 2015 47

Report Delivery

PDF SWOT Analysis Report An Electronic PDF copy of this Report will be sent to you via email.

Please allow up to 2 business days for the reports to arrive to your mailbox as some of our publishers prefer to send you the reports directly.

Purchase this Report today

Price: $125

Report Licences Explanation

* Single User: Electronic PDF copy delivered via email. Report can be used by individual purchaser only.

* Site License: Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.

* Enterprise Wide License: Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.

If you require a Site License or Enterprise Wide License please contact us to issue you an invoice.

Customers who Viewed this Report also Viewed

Risk warning: Your capital may be at risk. CFD trading is suitable for experienced traders and not beginners.